Mark E. Gurney
- Developmental Biology top 0.5%
- Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research 13
- Parkinson's Disease Mechanisms and Treatments 6
- Genetics top 1%
- Neurogenetic and Muscular Disorders Research 8
- Neurology top 2%
- Amyotrophic Lateral Sclerosis Research 13
- Parkinson's Disease Mechanisms and Treatments 6
- Pharmacology top 0.5%
- Cholinesterase and Neurodegenerative Diseases 14
- Inflammatory mediators and NSAID effects 6
-
- Phosphodiesterase function and regulation 22
- Receptor Mechanisms and Signaling 12
-
- Alzheimer's disease research and treatments 6
- Co-authors
- Masakazu KonishiEdward D. HallPaula K. AndrusAlex B. BurginTimothy J. FleckPing ZhaiJinhe LiAdele M. Pauley
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Annals of Neurology (4 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- United StatesIcelandUnited Kingdom
In The Last Decade
Mark E. Gurney
69 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Developmental Biology 536
- Neurology 1.5k
- Genetics 850
- Neurology 506
- Pharmacology 956
Countries citing papers authored by Mark E. Gurney
This map shows the geographic impact of Mark E. Gurney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Gurney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Gurney more than expected).
Fields of papers citing papers by Mark E. Gurney
This network shows the impact of papers produced by Mark E. Gurney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Gurney. The network helps show where Mark E. Gurney may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark E. Gurney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2021 | 20 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 26 | |
| 5 | 2021 | 85 | |
| 6 | 2020 | 32 | |
| 7 | 2020 | 59 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 20 | |
| 10 | 2018 | 40 | |
| 11 | 2017 | 53 | |
| 12 | 2011 | 29 | |
| 13 | 2009 | 94 | |
| 14 | 2008 | 15 | |
| 15 | 2001 | 324 | |
| 16 | 2001 | 1 | |
| 17 | 1998 | 114 | |
| 18 | 1997 | 85 | |
| 19 | 1995 | 33 | |
| 20 | 1993 | 17 |
About Mark E. Gurney
Mark E. Gurney is a scholar working on Developmental Biology, Pharmacology, Neurology, Genetics and Neurology, having authored 70 papers that have together received 5.3k indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (22 papers), Cholinesterase and Neurodegenerative Diseases (14 papers), Amyotrophic Lateral Sclerosis Research (13 papers), Receptor Mechanisms and Signaling (12 papers), Neurogenetic and Muscular Disorders Research (8 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), Alzheimer's disease research and treatments (6 papers) and Inflammatory mediators and NSAID effects (6 papers). The work is most often cited by research in Developmental Biology (536 citations), Neurology (1.5k citations), Genetics (850 citations), Neurology (506 citations) and Pharmacology (956 citations). Mark E. Gurney has collaborated with scholars based in United States, Iceland and United Kingdom. Frequent co-authors include Masakazu Konishi, Edward D. Hall, Paula K. Andrus, Alex B. Burgin, Timothy J. Fleck, Ping Zhai, Jinhe Li, Adele M. Pauley, Rong Xu and Lawrence C Katz. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Annals of Neurology, Journal of Medicinal Chemistry, Alzheimer s & Dementia and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.